Hospital Universitari Vall D Hebron
Hospital Universitari Vall D Hebron is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
Patient-Centered Study of Trastuzumab Deruxtecan (T-DXd) in First-Line HER2-Positive Metastatic Breast Cancer with Proactive Toxicity Management Reflecting Real-World Clinical Practice / TOP-REAL Trial
Sponsor Solti Group
- Start (EU)
- Latest update
- Estimated end
- Not reported
Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE (EAST-STROKE)
Sponsor University Medical Center Hamburg-Eppendorf
- Start (EU)
- Latest update
- Estimated end
Single cell characterization of persistent cells upon treatment with durvalumab (MEDI4736) with or without tremelimumab in MSS and MSI colorectal and endometrial tumors: the SERPENTINE clinical trial (Single cEll pRofiling PErsistaNce To ImmuNothErapy)
Sponsor Vall D Hebron Institute Of Oncology
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Hospital Universitari Vall D Hebron?
The 2026-10-09 snapshot links Hospital Universitari Vall D Hebron to 3 distinct CTIS trials. Recorded services include almacenar y etiquetar, Clinical monitoring, Laboratory services, Medical expertise, among 7 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Hospital Universitari Vall D Hebron?
The most frequently recorded therapeutic areas are Cardiology, Neurology, Solid Tumor Oncology. Recorded phases include Phase 2, Phase 4. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Hospital Universitari Vall D Hebron conducted?
The linked trials record locations in 4 countries, including Spain, Germany, France, Netherlands. These are trial locations, not confirmed office locations or countries where Hospital Universitari Vall D Hebron delivered services.
What can this page tell me about Hospital Universitari Vall D Hebron's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Hospital Universitari Vall D Hebron. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Hospital Universitari Vall D Hebron